Sfoglia per Autore  

Opzioni
Mostrati risultati da 41 a 60 di 61
Titolo Data di pubblicazione Autore(i) File
Risk factors and survival outcomes for upstaging after inguinal lymph node dissection for cN1 penile squamous cell carcinoma 1-gen-2021 Chakiryan, Nicholas H; Dahmen, Aaron; Bandini, Marco; Pederzoli, Filippo; Marandino, Laura; Albersen, Maarten; Roussel, Eduard; Zhu, Yao; Ye, Ding-Wei; Ornellas, Antonio A; Catanzaro, Mario; Hakenberg, Oliver W; Heidenreich, Axel; Haidl, Friederike; Watkin, Nick; Ager, Michael; Briganti, Alberto; Salvioni, Roberto; Montorsi, Francesco; Necchi, Andrea; Spiess, Philippe E
Molecular Characterization of Residual Bladder Cancer after Neoadjuvant Pembrolizumab 1-gen-2021 Necchi, A.; de Jong, J. J.; Raggi, D.; Briganti, A.; Marandino, L.; Gallina, A.; Bandini, M.; Dabbas, B.; Davicioni, E.; Capitanio, U.; Montorsi, F.; Seiler, R.; Wright, J. L.; Lotan, Y.; Black, P. C.; Gibb, E. A.
[18F]Fluoro-Deoxy-Glucose positron emission tomography to evaluate lymph node involvement in patients with muscle-invasive bladder cancer receiving neoadjuvant pembrolizumab 1-gen-2021 Marandino, L.; Capozza, A.; Bandini, M.; Raggi, D.; Fare, E.; Pederzoli, F.; Gallina, A.; Capitanio, U.; Bianchi, M.; Gandaglia, G.; Fossati, N.; Colecchia, M.; Giannatempo, P.; Serafini, G.; Padovano, B.; Salonia, A.; Briganti, A.; Montorsi, F.; Alessi, A.; Necchi, A.
Patterns of Recurrence following Inguinal Lymph Node Dissection for Penile Cancer: Optimizing Surveillance Strategies 1-gen-2021 Chakiryan, Nicholas H; Dahmen, Aaron; Bandini, Marco; Pederzoli, Filippo; Marandino, Laura; Albersen, Maarten; Roussel, Eduard; Zhu, Yao; Ye, Ding-Wei; Ornellas, Antonio A; Catanzaro, Mario; Hakenberg, Oliver W; Heidenreich, Axel; Haidl, Friederike; Watkin, Nick; Ager, Michael; Chahoud, Jad; Briganti, Alberto; Salvioni, Roberto; Montorsi, Francesco; Necchi, Andrea; Spiess, Philippe E
Assessing in-hospital morbidity after urethroplasty using the European Association of Urology Quality Criteria for standardized reporting 1-gen-2021 Bandini, M.; Barbagli, G.; Leni, R.; Cirulli, G. O.; Basile, G.; Balo, S.; Montorsi, F.; Sansalone, S.; Salonia, A.; Briganti, A.; Butnaru, D.; Lazzeri, M.
Re: Francesco Soria, Marco Moschini, David D'Andrea, et al. Comparative Effectiveness in Perioperative Outcomes of Robotic versus Open Radical Cystectomy: Results from a Multicenter Contemporary Retrospective Cohort Study. Eur Urol Focus 2020;6:1233–9 1-gen-2021 Montorsi, F.; Bandini, M.; Necchi, A.
A feasibility study of preoperative pembrolizumab before radical nephroureterectomy in patients with high-risk, upper tract urothelial carcinoma: PURE-02 1-gen-2021 Necchi, A.; Martini, A.; Raggi, D.; Cucchiara, V.; Colecchia, M.; Luciano, R.; Villa, L.; Mazzone, E.; Basile, G.; Scuderi, S.; Pederzoli, F.; Bandini, M.; Barletta, F.; Larcher, A.; Capitanio, U.; Salonia, A.; Briganti, A.; Ross, J. S.; Messina, A.; Montorsi, F.
Incidence and Clinical Impact of Inflammatory Fluorodeoxyglucose Positron Emission Tomography Uptake After Neoadjuvant Pembrolizumab in Patients with Organ-confined Bladder Cancer Undergoing Radical Cystectomy 1-gen-2021 Marandino, Laura; Capozza, Antonella; Bandini, Marco; Raggi, Daniele; Farè, Elena; Pederzoli, Filippo; Gallina, Andrea; Capitanio, Umberto; Bianchi, Marco; Gandaglia, Giorgio; Fossati, Nicola; Colecchia, Maurizio; Giannatempo, Patrizia; Serafini, Gianluca; Padovano, Barbara; Salonia, Andrea; Briganti, Alberto; Montorsi, Francesco; Alessi, Alessandra; Necchi, Andrea
Optimal pathological response after neoadjuvant chemotherapy for muscle-invasive bladder cancer: results from a global, multicentre collaboration 1-gen-2021 Ravi, P.; Pond, G. R.; Diamantopoulos, L. N.; Su, C.; Alva, A.; Jain, R. K.; Skelton, W. P.; Gupta, S.; Tward, J. D.; Olson, K. M.; Singh, P.; Grunewald, C. M.; Niegisch, G.; Lee, J. -L.; Gallina, A.; Bandini, M.; Necchi, A.; Mossanen, M.; Mcgregor, B. A.; Curran, C.; Grivas, P.; Sonpavde, G. P.
Bladder-sparing combination treatments for muscle-invasive bladder cancer: A plea for standardized assessment and definition of clinical trials endpoints 1-gen-2021 Basile, G.; Bandini, M.; Raggi, D.; Marandino, L.; Pederzoli, F.; Salonia, A.; Briganti, A.; Montorsi, F.; Kulkarni, S. B.; Necchi, A.
Causal contributors to tissue stiffness and clinical relevance in urology 1-gen-2021 Martinez-Vidal, L.; Murdica, V.; Venegoni, C.; Pederzoli, F.; Bandini, M.; Necchi, A.; Salonia, A.; Alfano, M.
Molecular subtyping and immune-gene signatures identify a subset of early bladder tumors as candidates for single-agent immune-checkpoint inhibition 1-gen-2021 Necchi, A.; Raggi, D.; Gallina, A.; Bandini, M.; de Jong, J. J.; Marandino, L.; Briganti, A.; Montorsi, F.; Davicioni, E.; Lotan, Y.; Gibb, E. A.
Clinical Outcomes of Patients With Metastatic Urothelial Carcinoma After Progression to Immune Checkpoint Inhibitors: A Retrospective Analysis by the Meet-Uro Group (Meet-URO 1 Study) 1-gen-2021 Bersanelli, M.; Buti, S.; Cortellini, A.; Bandini, M.; Banna, G. L.; Pederzoli, F.; Fare, E.; Raggi, D.; Giannatempo, P.; De Giorgi, U.; Basso, U.; Losanno, T.; Santini, D.; Mucciarini, C.; Tucci, M.; Tambaro, R.; Farnesi, A.; Caffo, O.; Veccia, A.; Naglieri, E.; Briganti, A.; Procopio, G.; Pignata, S.; Necchi, A.
Association of neurovascular bundle preservation with oncological outcomes in patients with high-risk prostate cancer 1-gen-2021 Preisser, F.; Gandaglia, G.; Arad, F.; Karakiewicz, P. I.; Bandini, M.; Pompe, R. S.; Montorsi, F.; Graefen, M.; Huland, H.; Briganti, A.; Tilki, D.
Is There a Detrimental Effect of Antibiotic Therapy in Patients with Muscle-invasive Bladder Cancer Treated with Neoadjuvant Pembrolizumab? 1-gen-2021 Pederzoli, F.; Bandini, M.; Raggi, D.; Marandino, L.; Basile, G.; Alfano, M.; Colombo, R.; Salonia, A.; Briganti, A.; Gallina, A.; Montorsi, F.; Necchi, A.
Incidental Prostate Cancer (cT1a-cT1b) Is a Relevant Clinical and Research Entity and Should Be Fully Discussed in the International Prostate Cancer Guidelines 1-gen-2021 Capitanio, Umberto; Autorino, Riccardo; Bandini, Marco; Briganti, Alberto; Cheng, Liang; Cooperberg, Matthew R; Dehò, Federico; Gallina, Andrea; Klotz, Laurence; Lane, Brian; Montironi, Rodolfo; Salonia, Andrea; Stief, Christian; Tombal, Bertrand; Montorsi, Francesco
A global approach to improving penile cancer care 1-gen-2022 Bandini, Marco; Ahmed, Mohamed; Basile, Giuseppe; Watkin, Nicholas; Master, Viraj; Zhu, Yao; Prakash, Gagan; Rodriguez, Alejandro; Ssebakumba, Mbaaga K; Leni, Riccardo; Cirulli, Giuseppe Ottone; Ayres, Ben; Compitello, Rachel; Pederzoli, Filippo; Joshi, Pankaj M; Kulkarni, Sanjay B; Montorsi, Francesco; Sonpavde, Guru; Necchi, Andrea; Spiess, Philippe E
Re: Updated Results of PURE-01 with Preliminary Activity of Neoadjuvant Pembrolizumab in Patients with Muscle-Invasive Bladder Carcinoma with Variant Histologies 1-gen-2022 Necchi, A.; Bandini, M.; Calareso, G.; Raggi, D.; Pederzoli, F.; Fare, E.; Colecchia, M.; Marandino, L.; Bianchi, M.; Gallina, A.; Colombo, R.; Fossati, N.; Gandaglia, G.; Capitanio, U.; Deho, F.; Giannatempo, P.; Luciano, R.; Salonia, A.; Madison, R.; Ali, S. M.; Chung, J. H.; Ross, J. S.; Briganti, A.; Montorsi, F.; De Cobelli, F.; Messina, A.
Neoadjuvant pembrolizumab and radical cystectomy in patients with muscle-invasive urothelial bladder cancer: 3-year median follow-up update of PURE-01 trial 1-gen-2022 Basile, Giuseppe; Bandini, Marco; Gibb, Ewan A; Ross, Jeffrey S; Raggi, Daniele; Marandino, Laura; Costa de Padua, Tiago; Crupi, Emanuele; Colombo, Renzo; Colecchia, Maurizio; Lucianò, Roberta; Nocera, Luigi; Moschini, Marco; Briganti, Alberto; Montorsi, Francesco; Necchi, Andrea
Advanced Squamous Cell Carcinomas of the Pelvic and Perineal Region: A Comprehensive Genomic Profiling Study 1-gen-2022 Necchi, Andrea; Spiess, Philippe E; Bandini, Marco; Basile, Giuseppe; Grivas, Petros; Bratslavsky, Gennady; Jacob, Joseph; Danziger, Natalie; Lin, Douglas; Decker, Brennan; Sokol, Ethan S; Huang, Richard S P; Kulkarni, Sanjay B; Ross, Jeffrey S
Mostrati risultati da 41 a 60 di 61
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile